Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,882Revenue $M25.8Net Margin (%)-215.5Altman Z-Score-3.2
Enterprise Value $M2,391EPS $-0.5Operating Margin %-13.8Piotroski F-Score4
P/E(ttm)--Beneish M-Score7.1Pre-tax Margin (%)-216.6Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-29.0Quick Ratio20.0Cash flow > EarningsY
Price/Sales71.25-y EBITDA Growth Rate %-38.1Current Ratio20.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-10.6Higher Current Ratio y-yY
Dividend Yield %6.2PEG--ROE % (ttm)-444.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M117ROIC % (ttm)-1.2Gross Margin Increase y-yN

Gurus Latest Trades with THRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THRXJoel Greenblatt 2015-06-30 Sold Out -0.01%$15.18 - $19.89
($17.15)
$ 16.07-6%Sold Out0
THRXFirst Eagle Investment 2015-06-30 Add0.01%$15.18 - $19.89
($17.15)
$ 16.07-6%Add 6.67%1,793,110
THRXJoel Greenblatt 2015-03-31 Buy 0.01%$10.68 - $20.2
($15.13)
$ 16.076%New holding52,837
THRXFirst Eagle Investment 2015-03-31 Add$10.68 - $20.2
($15.13)
$ 16.076%Add 5.48%1,680,910
THRXSeth Klarman 2014-09-30 Reduce-0.28%$17.53 - $30.4
($22.87)
$ 16.07-30%Reduce 2.84%19,815,983
THRXSeth Klarman 2014-06-30 Reduce-0.23%$21.154 - $30.1
($23.88)
$ 16.07-33%Reduce 1.50%20,395,056
THRXSeth Klarman 2014-03-31 Add0.42%$24.31 - $32.63
($29.32)
$ 16.07-45%Add 2.79%20,705,801
THRXSeth Klarman 2013-12-31 Add1.65%$27.19 - $32.81
($29.19)
$ 16.07-45%Add 8.83%20,144,301
THRXFirst Eagle Investment 2013-12-31 Add0.03%$27.19 - $32.81
($29.19)
$ 16.07-45%Add 23.40%1,509,404
THRXSeth Klarman 2013-09-30 Add2.3%$28.86 - $34.36
($31.06)
$ 16.07-48%Add 11.92%18,510,371
THRXSeth Klarman 2013-06-30 Add2.85%$18.15 - $33.74
($26.83)
$ 16.07-40%Add 22.02%16,538,977
THRXFirst Eagle Investment 2013-06-30 Add0.08%$18.15 - $33.74
($26.83)
$ 16.07-40%Add 139.14%1,109,620
THRXFirst Eagle Investment 2012-06-30 Add0.01%$14.11 - $19.04
($16.72)
$ 16.07-4%Add 24.23%509,710
THRXSeth Klarman 2012-03-31 Add0.22%$13.21 - $16.28
($13.91)
$ 16.0716%Add 2.30%14,553,800
THRXFirst Eagle Investment 2012-03-31 Add0.01%$13.21 - $16.28
($13.91)
$ 16.0716%Add 25.59%410,310
THRXJulian Robertson 2011-09-30 Sold Out -1.2512%$14.05 - $20.04
($16.74)
$ 16.07-4%Sold Out0
THRXSeth Klarman 2011-09-30 Add0.84%$14.05 - $20.04
($16.74)
$ 16.07-4%Add 9.76%14,225,961
THRXFirst Eagle Investment 2011-06-30 Reduce-0.02%$17.07 - $23.13
($20)
$ 16.07-20%Reduce 33.79%326,710
THRXDavid Swensen 2011-03-31 Sold Out -6.58%$16.91 - $20.77
($18.79)
$ 16.07-14%Sold Out0
THRXJulian Robertson 2011-03-31 Reduce-0.35%$16.91 - $20.77
($18.79)
$ 16.07-14%Reduce 20.94%211,686
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


THRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLC10% Owner 2015-08-07Buy245,828$3485840-100view
Tyree James LDirector 2015-06-02Sell2,438$16.85-8.61view
WALTRIP WILLIAM HDirector 2015-05-27Sell16,313$16.32-5.64view
GLAXOSMITHKLINE PLC10% Owner 2015-05-11Buy85,579$1369260-100view
GLAXOSMITHKLINE PLC10% Owner 2015-03-02Buy92,674$18.06-14.73view
GLAXOSMITHKLINE PLC10% Owner 2014-11-04Buy832,456$15.360.26view
LEE JUNNINGSr. VP, Technical Operations 2014-08-13Sell53,424$22.5-31.56view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-08-12Sell28,156$22.13-30.41view
GLAXOSMITHKLINE PLC10% Owner 2014-08-11Buy172,651$22.66-32.04view
GLAXOSMITHKLINE PLC10% Owner 2014-05-09Buy317,770$26.89-42.73view

Press Releases about THRX :

Quarterly/Annual Reports about THRX:

    News about THRX:

    Articles On GuruFocus.com
    Theravance to Present at Two Upcoming Investor Conferences in September Sep 02 2015 
    GSK Receives Approval for BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma Aug 06 2015 
    Theravance to Report Second Quarter 2015 Financial Results on July 29, 2015 Jul 22 2015 
    Theravance, Inc. Appoints Michael Faerm as Chief Business Officer Jul 13 2015 
    main Jul 11 2015 
    main Jul 01 2015 
    main Jul 01 2015 
    Insiders' New Buys : MAC, SPB, PDVW, HNSN, THRX, RSG, CVX May 18 2015 
    Seth Klarman's Trades During Q1 2015 Apr 20 2015 
    Richard Perry's Fourth-Quarter Transactions Had High Impact on Portfolio Feb 16 2015 

    More From Other Websites
    Theravance Biopharma Announces New Employment Inducement Awards Sep 02 2015
    Theravance to Present at Two Upcoming Investor Conferences in September Sep 02 2015
    Theravance Biopharma to Present at the Baird 2015 Healthcare Conference Aug 27 2015
    THERAVANCE INC Financials Aug 14 2015
    GSK hopes big clinical trial can breath new life into lung drug Aug 13 2015
    GSK hopes big clinical trial can breath new life into lung drug Aug 13 2015
    Theravance, Inc. Earnings Q2*, 2015 Aug 13 2015
    Theravance Biopharma, Inc. Reports Second Quarter 2015 Financial Results and Provides Business... Aug 10 2015
    10-Q for Theravance, Inc. Aug 08 2015
    THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 06 2015
    GSK Receives Approval for BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma Aug 06 2015
    THERAVANCE INC Files SEC form 10-Q, Quarterly Report Aug 06 2015
    Theravance Biopharma Receives FDA Fast Track Designation for TD-8954 for Use With Enteral Feeding in... Aug 06 2015
    Theravance Biopharma Announces New Employment Inducement Awards Aug 04 2015
    Theravance Biopharma to Present at the Wedbush PacGrow Healthcare Conference Jul 30 2015
    Edited Transcript of THRX earnings conference call or presentation 29-Jul-15 9:00pm GMT Jul 30 2015
    Theravance reports 2Q loss Jul 29 2015
    Theravance reports 2Q loss Jul 29 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK